Liu G, Zhang Y, Zhang W, Wu X, Gao H, Jiang H
Sex Med. 2022; 10(3):100509.
PMID: 35398789
PMC: 9177876.
DOI: 10.1016/j.esxm.2022.100509.
Platzer M, Fellendorf F, Bengesser S, Birner A, Dalkner N, Hamm C
Nutrients. 2021; 13(1).
PMID: 33383670
PMC: 7824587.
DOI: 10.3390/nu13010076.
Ouanounou A, Ng K
Can J Dent Hyg. 2020; 53(3):172-177.
PMID: 33240356
PMC: 7533804.
Grover S, Nebhinani N, Chakrabarti S, Avasthi A, Kulhara P
Indian J Psychol Med. 2013; 35(2):167-73.
PMID: 24049228
PMC: 3775049.
DOI: 10.4103/0253-7176.116247.
Ananloo E, Ghaeli P, Kamkar M, Sadeghi M
Daru. 2013; 21(1):4.
PMID: 23351476
PMC: 3556056.
DOI: 10.1186/2008-2231-21-4.
The association between conventional antidepressants and the metabolic syndrome: a review of the evidence and clinical implications.
McIntyre R, Park K, Law C, Sultan F, Adams A, Lourenco M
CNS Drugs. 2010; 24(9):741-53.
PMID: 20806987
DOI: 10.2165/11533280-000000000-00000.
The distinct effects of subchronic antipsychotic drug treatment on macronutrient selection, body weight, adiposity, and metabolism in female rats.
Fell M, Anjum N, Dickinson K, Marshall K, Peltola L, Vickers S
Psychopharmacology (Berl). 2007; 194(2):221-31.
PMID: 17581744
DOI: 10.1007/s00213-007-0833-9.
Fluoxetine: a review of its therapeutic potential in the treatment of depression associated with physical illness.
Cheer S, Goa K
Drugs. 2001; 61(1):81-110.
PMID: 11217873
DOI: 10.2165/00003495-200161010-00010.
Bodyweight change as an adverse effect of drug treatment. Mechanisms and management.
Pijl H, Meinders A
Drug Saf. 1996; 14(5):329-42.
PMID: 8800628
DOI: 10.2165/00002018-199614050-00005.
Inhibition of foot intake in the rat.
Blavet N, Defeudis F
Neurochem Res. 1982; 7(3):339-48.
PMID: 7110507
DOI: 10.1007/BF00965645.
Adverse effects of antidepressant drugs. Part 2: 'Second generation' antidepressants and rational decision making in antidepressant therapy.
Blackwell B
Drugs. 1981; 21(4):273-82.
PMID: 7014171
DOI: 10.2165/00003495-198121040-00003.
Drug-induced weight gain.
Kalucy R
Drugs. 1980; 19(4):268-78.
PMID: 6991239
DOI: 10.2165/00003495-198019040-00002.
Treatment of bulimia with antidepressants.
Pope Jr H, Hudson J
Psychopharmacology (Berl). 1982; 78(2):176-9.
PMID: 6817375
DOI: 10.1007/BF00432258.
Effect of zimelidine, a new antidepressant, on appetite and body weight.
Simpson R, Lawton D, Watt M, Tiplady B
Br J Clin Pharmacol. 1981; 11(1):96-8.
PMID: 6452151
PMC: 1401706.
DOI: 10.1111/j.1365-2125.1981.tb01112.x.
Differential diagnosis of emotional disorders that cause weight loss.
Garfinkel P, Garner D, Kaplan A, Rodin G, Kennedy S
Can Med Assoc J. 1983; 129(9):939-45.
PMID: 6367916
PMC: 1875814.
Current antidepressant drugs: their clinical use.
Hollister L
Drugs. 1981; 22(2):129-52.
PMID: 6114851
DOI: 10.2165/00003495-198122020-00003.
Editorial: Drugs causing weight gain.
Br Med J. 1974; 1(5900):168.
PMID: 4811842
PMC: 1633045.
The risk-benefit assessment of antidepressant drugs.
Henry J, Martin A
Med Toxicol Adverse Drug Exp. 1987; 2(6):445-62.
PMID: 3323776
DOI: 10.1007/BF03259878.
Reduction of sucrose preference by chronic unpredictable mild stress, and its restoration by a tricyclic antidepressant.
Willner P, Towell A, Sampson D, Sophokleous S, Muscat R
Psychopharmacology (Berl). 1987; 93(3):358-64.
PMID: 3124165
DOI: 10.1007/BF00187257.
Chronic effects of fluoxetine, a selective inhibitor of serotonin uptake, on neurotransmitter receptors.
Wong D, REID L, Bymaster F, Threlkeld P
J Neural Transm. 1985; 64(3-4):251-69.
PMID: 3003252
DOI: 10.1007/BF01256471.
